{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:48:38Z","timestamp":1775044118926,"version":"3.50.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,28]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Selection of an antibiotic and dosing regimen requires consideration of multiple factors including microbiological data, site of infection, pharmacokinetics, and how it relates to the pharmacodynamic target. Given the multiple dosage regimens of amoxicillin with\/without clavulanate and cephalexin, we review the principles of dose selection from a pharmacist\u2019s perspective.<\/jats:p>","DOI":"10.1093\/jpids\/piac105","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T16:27:16Z","timestamp":1663345636000},"page":"594-602","source":"Crossref","is-referenced-by-count":5,"title":["Shedding Light on Amoxicillin, Amoxicillin-clavulanate, and Cephalexin Dosing in Children from a Pharmacist\u2019s Perspective"],"prefix":"10.1093","volume":"11","author":[{"given":"Diana","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Doernbecher Children\u2019s Hospital, Oregon Health and Science University , Portland, Oregon , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9520-6420","authenticated-orcid":false,"given":"Laura L","family":"Bio","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Lucile Packard Children\u2019s Hospital Stanford , Palo Alto, California , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"2022122811310536800_CIT0001","first-page":"1308","article-title":"US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011","volume":"60","author":"Hicks","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2022122811310536800_CIT0002","first-page":"251","article-title":"Penicillins and \u03b2-lactamase inhibitors.","volume-title":"Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases","author":"Doi","year":"2020","edition":"9"},{"key":"2022122811310536800_CIT0003","first-page":"268","article-title":"Cephalosporins.","volume-title":"Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases","author":"Lepak","year":"2020","edition":"9"},{"key":"2022122811310536800_CIT0004","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1093\/jac\/dkz252","article-title":"Oral antibiotics for neonatal infections: a systematic review and meta-analysis","volume":"74","author":"Keij","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2022122811310536800_CIT0005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1086\/510079","article-title":"Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it\u2019s not just for mice anymore","volume":"44","author":"Ambrose","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2022122811310536800_CIT0006","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.mib.2013.06.010","article-title":"PK\/PD models in antibacterial development","volume":"16","author":"Morris","year":"2013","journal-title":"Curr Opin Microbiol"},{"key":"2022122811310536800_CIT0007","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/ajhp\/zxz344","article-title":"Surgical site infection rate is higher following hip and knee arthroplasty when cefazolin is underdosed","volume":"77","author":"Velkov","year":"2020","journal-title":"Am J Health Syst Pharm"},{"key":"2022122811310536800_CIT0008","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/jac\/dkm476","article-title":"Tissue concentrations: do we ever learn?","volume":"61","author":"Mouton","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"2022122811310536800_CIT0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"2022122811310536800_CIT0010","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2022122811310536800_CIT0011","doi-asserted-by":"crossref","first-page":"e964","DOI":"10.1542\/peds.2012-3488","article-title":"The diagnosis and management of acute otitis media","volume":"131","author":"Lieberthal","year":"2013","journal-title":"Pediatrics"},{"key":"2022122811310536800_CIT0012","volume-title":"Performance Standards for Antimicrobial Testing","author":"Clinical and Laboratory Standards Institute (CLSI).","year":"2022","edition":"32"},{"key":"2022122811310536800_CIT0013","first-page":"222","article-title":"Molecular mechanisms of antibiotic resistance in bacteria.","volume-title":"Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases","author":"Opal","year":"2020","edition":"9"},{"key":"2022122811310536800_CIT0014","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1016\/j.ijantimicag.2007.07.039","article-title":"The use of pharmacokinetic\/pharmacodynamic principles to predict clinical outcome in paediatric acute otitis media","volume":"30","author":"Dagan","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"2022122811310536800_CIT0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta25600","article-title":"Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCT","volume":"25","author":"Barratt","year":"2021","journal-title":"Health Technol Assess"},{"key":"2022122811310536800_CIT0016","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1542\/pir.2016-0183","article-title":"Management of pediatric community-acquired bacterial pneumonia","volume":"38","author":"Messinger","year":"2017","journal-title":"Pediatr Rev"},{"key":"2022122811310536800_CIT0017","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/INF.0b013e3181f42a53","article-title":"Pharmacokinetics, pharmacodynamics, and Monte Carlo simulation: selecting the best antimicrobial dose to treat an infection","volume":"29","author":"Bradley","year":"2010","journal-title":"Ped Infect Dis J"},{"key":"2022122811310536800_CIT0018","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1128\/AAC.47.3.997-1001.2003","article-title":"Comparing pharmacokinetics of amoxicillin given twice or three times per day to children older than 3 months with pneumonia","volume":"47","author":"Fonseca","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"2022122811310536800_CIT0019","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1093\/ofid\/ofy263","article-title":"Antimicrobial susceptibility of Streptococcus pneumoniae from North America, Europe, Latin America, and the Asia-Pacific region: results from 20 years of the SENTRY antimicrobial surveillance program (1997\u20132016)","volume":"6","author":"Sader","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2022122811310536800_CIT0020","author":"JMI Laboratories."},{"key":"2022122811310536800_CIT0021","author":"European Committee on Antimicrobial Susceptibility Testing.","year":"2017"},{"key":"2022122811310536800_CIT0022","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijid.2019.02.005","article-title":"Antibiotic penetration into bone and joints: an updated review","volume":"81","author":"Thabit","year":"2019","journal-title":"Int J Infect Dis"},{"key":"2022122811310536800_CIT0023","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1093\/cid\/cis629","article-title":"Clinical practice guideline for the diagnosis and management of Group A Streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America","volume":"55","author":"Shulman","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2022122811310536800_CIT0024","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3390\/antibiotics9080525","article-title":"Amoxicillin-clavulanic acid empirical oral therapy for the management of children with acute haematogenous osteomyelitis","volume":"9","author":"Serrano","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"2022122811310536800_CIT0025","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/jpids\/piab027","article-title":"Clinical practice guideline by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America: 2021 guideline on diagnosis and management of acute hematogenous osteomyelitis in pediatrics","volume":"10","author":"Woods","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2022122811310536800_CIT0026","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/phar.2210","article-title":"Pharmacokinetics and pharmacodynamics of beta-lactamase inhibitors","volume":"39","author":"Crass","year":"2019","journal-title":"Pharmacotherapy"},{"key":"2022122811310536800_CIT0027","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/INF.0000000000002646","article-title":"Twice- and thrice-daily cephalexin dosing for Staphylococcus aureus infections in children","volume":"39","author":"Gwee","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"2022122811310536800_CIT0028","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1097\/INF.0b013e3182a222a6","article-title":"Pharmacokinetics and pharmacodynamics of oral cephalexin in children with osteoarticular infections","volume":"32","author":"Autmizguine","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"2022122811310536800_CIT0029","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/INF.0000000000002661","article-title":"Frequency of dosing of cephalexin for oral step-down therapy of pediatric osteoarticular infections caused by methicillin-sensitive Staphylococcus aureus","volume":"39","author":"Ramchandar","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"2022122811310536800_CIT0030","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/8755122518755402","article-title":"Antimicrobial pharmacotherapy management of urinary tract infections in pediatric patients","volume":"34","author":"Lashkar","year":"2018","journal-title":"J Pharm Technol"},{"key":"2022122811310536800_CIT0031","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s10096-019-03679-9","article-title":"A pharmacokinetic-pharmacodynamic assessment of oral antibiotics for pyelonephritis","volume":"38","author":"Cattrall","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2022122811310536800_CIT0032","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/bmj.39244.692442.55","article-title":"Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non-inferiority trial","volume":"335","author":"Montini","year":"2007","journal-title":"BMJ"},{"key":"2022122811310536800_CIT0033","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1097\/PEC.0000000000001342","article-title":"Improving antibiotic prescribing for children with urinary tract infection in emergency and urgent care settings","volume":"36","author":"Poole","year":"2020","journal-title":"Pediatr Emerg Care"},{"key":"2022122811310536800_CIT0034","first-page":"683","article-title":"Outpatient treatment of acute pyelonephritis in pregnancy after 24 weeks","volume":"94","author":"Wing","year":"1999","journal-title":"Obstet Gynecol"},{"key":"2022122811310536800_CIT0035","first-page":"419","article-title":"Impact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysis","volume":"7","author":"Srivastava","year":"2013","journal-title":"Patient Prefer Adherence"},{"key":"2022122811310536800_CIT0036","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1093\/cid\/cis370","article-title":"IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults","volume":"54","author":"Chow","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2022122811310536800_CIT0037","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.1542\/peds.2013-1071","article-title":"Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years","volume":"132","author":"Wald","year":"2013","journal-title":"Pediatrics"},{"key":"2022122811310536800_CIT0038","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Steven","year":"2014","journal-title":"Clin Infec Dis"},{"key":"2022122811310536800_CIT0039","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1542\/peds.2011-1330","article-title":"Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months","volume":"128","author":"Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management","year":"2011","journal-title":"Pediatrics"},{"key":"2022122811310536800_CIT0040","doi-asserted-by":"crossref","first-page":"e013299","DOI":"10.1136\/bmjopen-2016-013299","article-title":"Acute uncomplicated appendicitis study: rationale and protocol for a multicentre, prospective randomised controlled non-inferiority study to evaluate the safety and effectiveness of non-operative management in children with acute uncomplicated appendicitis","volume":"6","author":"Xu","year":"2016","journal-title":"BMJ Open"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpids\/advance-article-pdf\/doi\/10.1093\/jpids\/piac105\/46698489\/piac105.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/11\/12\/594\/48438030\/piac105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/11\/12\/594\/48438030\/piac105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:57:02Z","timestamp":1701046622000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/11\/12\/594\/6702274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,9,16]]},"published-print":{"date-parts":[[2022,12,28]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piac105","relation":{},"ISSN":["2048-7207"],"issn-type":[{"value":"2048-7207","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12,1]]},"published":{"date-parts":[[2022,9,16]]}}}